期刊文献+

不同筛查工具对食管癌患者营养筛查的比较

Comparison of different tools for nutritional screening in patients with esophageal cancer
下载PDF
导出
摘要 目的本研究前瞻性评估食管癌患者的营养风险,比较不同营养筛查工具间的差异。方法前瞻性评估54例食管癌患者营养状况,利用营养风险筛查(NRS 2002)及主观全面评价法(SGA)作营养筛查,测定体重指数判断营养状况,分析各营养筛查方法的关系。结果 54例患者均完成NRS 2002和SGA。用体重指数(BMI)中国标准判定营养不足、超重和肥胖发生率分别为7.4%、18.5%和5.6%。NRS 2002筛查显示营养风险发生率为79.6%,SGA筛查显示营养不足发生率为81.5%。两种方法在营养不足筛查结果间差异无统计学意义(P=0.723)。结论 NRS2002和SGA均适用于食管癌患者营养风险筛查。 Objective To prospectively assess the nutritional risk in patients with esophageal cancer,and compare the feasibility and results of nutritional risk screening 2002(NRS 2002) and subjective globe assessment(SGA).Methods Fifty four patients with esophageal cancer were selected for nutritional status survey including human body measurement,blood biochemical index, subjective global assessment(SGA),and nutritional risk screening 2002(NRS 2002).Results All patients completed both NRS 2002 and SGA.The incidences of undernutrition,overweight,and obesity judged by Chinese standard of body mass index(BMI) were 7.4%,18.5%and 5.6%. respectively.The incidences of nutritional risk or undernutrition screened by NRS2002 and SGA were 79.6%and 81.5%,respectively.No significant difference was observed between the results of these two screening tools(P = 0.723).Conclusion Both NRS 2002 and SGA were feasible in screening undernutrition in esophageal cancer patients.
出处 《消化肿瘤杂志(电子版)》 2009年第1期59-61,共3页 Journal of Digestive Oncology(Electronic Version)
关键词 营养风险 营养风险筛查 主观全面评价法 nutritional risk Nutritional Risk Screening 2002 Subjective Globe Assessment
  • 相关文献

参考文献6

  • 1Mantovani G,Macci(o) A,Lai P. Cytokine activity in cancer-related anorexia/cachexia:role of megestrol acetate and medroxyprogesterone acetate[J].Seminars in Oncology,1998,(z6):45-52.
  • 2De Blaauw I,Heeneman S,Deutz NE. Increased whole-body protein and glutamine turnover in advanced cancer is not matched by an increased muscle protein and glutamine turnover[J].Journal of Surgical Research,1997,(01):44-55.doi:10.1006/jsre.1997.5007.
  • 3夏照华,胡昆卓,王正,杨林,欧竹君,林少霖.恶性肿瘤患者体质量减轻的治疗进展[J].临床荟萃,2008,23(1):74-76. 被引量:2
  • 4夏照华,胡昆卓,王正,杨林,林少霖,欧竹君.住院患者能量消耗和营养支持的研究进展[J].实用医学杂志,2008,24(16):2906-2907. 被引量:7
  • 5Kondrup J,Allison SP,Elia M. ESPEN guidelines for nutrition screening 2002[J].Clinical Nutrition,2003,(04):415-421.doi:10.1016/S0261-5614(03)00098-0.
  • 6Kondrup J,Rasmussen HH,Hamberg O. Nutritional risk screening (NRS 2002):a new method based on an analysis of controlled clinical trials[J].Clinical Nutrition,2003,(03):321-336.doi:10.1016/S0261-5614(02)00214-5.

二级参考文献30

  • 1Malik NM, Liu dexamethasone, YL, Cole N, et al. Differential effects of ondansetron and a tachykinin NK1receptor antagonist ( GR205171 ) on cisplatin-induced changes in behaviour, food intake, pica and gastric function in rats[J]. Eur J Pharmacol,2007,555(2-3) :164-173.
  • 2Khan ZH ,Simpson EJ, Cole AT, et al. Oesophageal cancer and cachexia:the effect of short-term treatment with thalidomide on weight loss and lean body mass[J]. Aliment Pharmacol Ther, 2003,17(5) :677-682.
  • 3Bruera E, Strasser F, Palmer JL, et al. Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia:a double-blind placebo-controlled study [J]. J Clin Oncol,2003,21(1) :129-134.
  • 4Fearon KC, von Meyenfeldt MF, Moses AG, et al. Effect of protein and energy dense N-3 fatty acid enriched oral supplement of loss of weight and lean tissue in cancer caehexia: a randomized double blind trial[J]. Gut, 2003,52 (10) : 1391- 1392.
  • 5Persson C,Glimelius B, Ronnelid J, et al. Impact of fish oil and melatonin on caehexia in patients with advanced gastrointestinal cancer:a randomized pilot study[J]. Nutrition, 2005,21 (2) : 170-178.
  • 6Palombine J. Cancer-related weight loss[J]. Clin J Oncol Nurs, 2006,10(6) :831-832.
  • 7Skipworth RJ,Stewart GD, Dejong CH, et al. Pathophysiology of cancer eaehexia: Much more than host-tumor interaction[J] ? Clin Nutr,2007,26(4):433-437.
  • 8Tomiska M, Tomiskova M, Salajka F, et al. Palliative treatment of cancer anorexia with oral suspension of megestrol acetate [J]. Neoplasma, 2003,50(3) :227-233.
  • 9Diament MJ,Peluffo GD, Stillitani I, et al. Inhibition of tumor progression and paraneoplastic syndrome development in a murine lung adenocareinoma by medroxyprogesterone acetate and indomethaein[J]. Cancer Invest,2006,24(2) : 126-131.
  • 10Jatoi A, Windschitl HE, Loprinzi CL, et al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia:a North Central Cancer Treatment Group Study[J]. J Clin Oncol, 2002,20(2) : 567-573.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部